CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Revenue, Net	$ 2,597.9	$ 2,372.7	$ 7,504.4	$ 7,049.9
Reimbursement Revenue	57.3	42.0	140.7	163.5
Revenues	2,655.2	2,414.7	7,645.1	7,213.4
Cost of sales	1,715.1	1,584.3	4,956.2	4,657.4
Cost of Reimbursable Expense	57.3	42.0	140.7	163.5
Cost of Revenue	1,772.4	1,626.3	5,096.9	4,820.9
Gross profit	882.8	788.4	2,548.2	2,392.5
Selling, general and administrative expenses	465.3	400.5	1,320.0	1,224.2
Amortization of intangibles and other assets	54.6	41.1	153.6	130.7
Net restructuring and other special charges	21.6	22.8	64.6	48.6
Operating Income (Loss)	341.3	324.0	1,010.0	989.0
Other income (expenses):
Interest expense	(59.9)	(58.2)	(167.3)	(166.2)
Equity method income, net	3.2	2.6	10.0	5.9
Investment income	0.7	0.6	1.4	1.5
Other, net	(4.2)	(5.6)	(8.2)	(1.3)
Earnings before income taxes	281.1	263.4	845.9	828.9
Provision for income taxes	97.7	83.6	281.1	280.3
Net earnings	183.4	179.8	564.8	548.6
Less: Net earnings attributable to the noncontrolling interest	(2.8)	(0.3)	(3.4)	(0.9)
Net earnings attributable to Laboratory Corporation of America Holdings	$ 180.6	$ 179.5	$ 561.4	$ 547.7
Basic earnings per common share (in dollars per share)	$ 1.77	$ 1.74	$ 5.48	$ 5.36
Diluted earnings per common share (in dollars per share)	$ 1.74	$ 1.71	$ 5.40	$ 5.25